Term
|
Definition
Constitutive expression in tissues
Protein levels are constant
Synthesized prostanoids for housekeeping
Purposes: gastric protection, kidney function, blood clotting
Inhibition leads to GI related side effects |
|
|
Term
|
Definition
Express induced by stress, growth factors, cytokines, and inflammatory mediators
Sources involve cancer and inflammation
Tissue specific effects
Inhibition leads to anti-pyretic, analgesic, and anti-inflammatory actions of the NSAIDs
Selective inhibition can cause less GI toxicity |
|
|
Term
|
Definition
Mild analgesia (MSK pain)
Effective where inflammation has sensitized pain receptors
Can be additive to opioids
Elevates set point of fever in hypothalamus
Inflammation, particularly MSK disorders (RA, OA)
Symptomatic relief
Closure of PDA
Chemoprevention |
|
|
Term
|
Definition
GI pain, nausea, diarrhea, hemorrhage, ulcers, perforation
Renal insufficiency, failure, hyperkalemia, proteinuria
Decreased effecs of anti-hypertensives
Decreased excretion due to effect on arterioles (esp ASA)
Analgesic nephropathy
Selective inhibition of PGI2 (and not TXA) can lead to platelet aggregation
Increased gestation and inhibition of labor
Post-partum hemorrhage
Vasomotor rhinitis
Angioneuritic edema
Asthma
Urticaria, flushing |
|
|
Term
|
Definition
ACE + NSAID + hyperkalemia = bradycardia and syncope
Attenuates effects of ACE inhibitors
Warfarin - CYP enzymes
NSAIDs inhibit metabolism of warfarin - increased propensity for bleeding
|
|
|
Term
|
Definition
Often occurs in children
Coma, convulsions, cardiovascular collapse
Mild headache, dizziness, tinnitus, drowsiness, sweating, thirst, hyperventilation, nausea, vomiting
High doses: CNS stimulation and depression, hyperthermia
Respiratory alkalosis and eventual acidosis |
|
|
Term
|
Definition
Reactive metabolite benzoquinone imine
Occurs when gluthione is depleted
Single doses 10-15 g
Nausea, ab pain, anorexia
Serum transaminases can be elevated
Hepatic damage occurs at 2-4 days
Exacerbated by alcohol and malnutrition
Tx: activated charcoal, Mucomyst, supportive care
|
|
|
Term
|
Definition
Willowbark
Competitive and irreversible inhibitor of COX1 and COX2
Analgesia, Antipyretic at low doses, Anti-inflammatory at high doses, blood thinner, keratolytic, uricosuric
Indicated for pain, fever, inflammation, CV disease, UC, gout, RA, cancer
Can get Reye's syndrome if given with viral infection
First pass metabolism --> salicylate
Excreted renally |
|
|
Term
|
Definition
NSAID with no effects on respiratory, CV, GI tract, platelets, coagulation, acid-base status, or uric acid
Used for analgesia and fever, but not inflammation
Can be combined with opioids
Well absored
Metabolized by glucuronic acid |
|
|
Term
|
Definition
Most commonly used NSAID
2400 mg for inflammation
2 hour half life
Indications: PDA closure, topical relief of OA
May co-admin with ASA for cardioprotective effects
GI effects in 15% |
|
|
Term
|
Definition
Single enantiomer NSAID
14 hour half life
Used in RA |
|
|
Term
|
Definition
Older NSAID that is a stronger analgesic than aspirin
Indications: PDA closure, gout, ankylosing spondylitis
Opthalmic prep and oral rinse
Adverse effects can be more severe |
|
|
Term
|
Definition
NSAID that inhibits leukocyte migration in high doses
Absorbed completely
Food delays absorption
50 hour half life allows for once daily dosing
Indicated for RA |
|
|
Term
|
Definition
A pro-drug NSAID that undergoes enterohepatic cycling
Indications: familial polyps, cancers
Side effects: Stevens-Johnson syndrome, thrombocytopenia, agranulocytosis, nephrotic syndrome, and liver damage |
|
|
Term
|
Definition
A selective COX2 inhibitor
11 hour half life
Has less GI side effects than non-selective NSAIDs
Side effects: thrombosis, hypertension, atherogenesis
Metabolizes SSRIs
Metabolized by microsomal enzymes |
|
|
Term
Drugs with Mineralocorticoid activity |
|
Definition
Aldosterone (only)
Cortisol
Prednisolone
Methylprednisolone
Fludrocortisone |
|
|
Term
Drugs with Glucocorticoid activity |
|
Definition
Cortisol
Prednisolone (mostly)
Methylprednisolone (mostly)
Dexamethasone (only)
Fludrocortisone |
|
|
Term
Features of Mineralocorticoids |
|
Definition
Influence water and electrolyte balance
Made in Zona glomerulosa
Does not respond to ACTH stimulus
Mineralocorticoid receptors bind aldosterone and glucocorticoids (an enzyme exists to prevent cortisol from binding) |
|
|
Term
Features of Glucocorticoids |
|
Definition
Anti-inflammatory agents that have effects on carbs and protein metabolism
Made in Zona fasciculata
Responds to ACTH and stress |
|
|
Term
|
Definition
Made in zona reticularis
Responds to ACTH |
|
|
Term
Physiologic Effects of Glucocorticoids |
|
Definition
Carb and protein metabolism to maintain blood glucose levels
Synthesis of glucose, glycogen deposition, protein breakdown, increase of FFA, stimulation of hormones (NE, epi, GH), decrease lymphocytes, eosinophils, monocytes, basophils, decreased lymphoid mass, decrease in TNF
Alter immune response of lymphocytes, cytokine releas
Decreased prostaglandin and leukotrienes
Inhibition of arachidonic acid, leukotrienes, COXs |
|
|
Term
Glucocorticoid Toxicity due to Excess |
|
Definition
HTN, Cushing's syndrome, muscle wasting, HPA suppression, hyperglycemia, immune system syppression, osteoporosis, osteonecrosis, myopathy, cataracts, psychosis, euphoria, growth suppression in children |
|
|
Term
Glucocorticoid Toxicity due to Sudden Cessation |
|
Definition
acute adrenal insufficiency
Fever, myalgias, arthritis, malaise
Weeks to months recovery with slow taper |
|
|
Term
Therapeutic Uses of Glucocorticoids |
|
Definition
Anti-inflammatory, Immunosuppressive, Rheumatic carditis, Leukemias, SLE, nephrotic syndrome, polyarteritis nodosa, pemphigus, RA, asthma, allergic rhinitis, IBD, stroke and spinal cord injury |
|
|
Term
|
Definition
Mineralocorticoid that is produced in the zona glomerulosa that alters Na and water reabsorption in the kidney.
Indications: nephrogenic DI |
|
|
Term
|
Definition
Endogenous hormone with glucocorticoid and mineralocorticoid activity that works as an anti-inflammatory and immunosuppressant
Responds to ACTH and has a negative feedback inhibition to the pituitary and hypothalamus |
|
|
Term
|
Definition
Hormone made in opthalmic prep that has mainly glucocorticoid activity with some mineralocorticoid activity.
Used in eye inflammation |
|
|
Term
|
Definition
Oral prep hormone that has mostly glucocorticoid activity with some mineralocorticoid activity
Used as an anti-inflammatory |
|
|
Term
|
Definition
Hormone with glucocorticoid activity that can be given as oral, opthalmic, or topical prep
Used to diagnose hypercorticism, arthritis, systemic disorders, severe allergies, asthma, and cancers |
|
|
Term
|
Definition
Hormone with mostly mineralocorticoid and some glucocorticoid activity that is used to control fluid and electrolyte imbalance
Used in Addison's disease |
|
|
Term
Mechanisms of Nitroglycerin |
|
Definition
1. Relax venous smooth muscle at low doses and arterial smooth muscle at high doses to decrease preload during diastole, increase coronary blood flow
2. Decreases oxygen demand of cardiac muscle by decreasing tension on cardiac walls
3. Dilate epicaridal coronary vessels (preferential to the ones that need oxygen) |
|
|
Term
Effects of DHPR Ca Channel Blockers |
|
Definition
Relaxes smooth muscle at lower concentrations than those required to reduce Ca influex into cardiac cells
Generally decreases arterial resistance and BP
Reflex increase in CO
Decrease coronary resistance
Increases coronary blood flow
Decreases oxygen demand of myocytes |
|
|
Term
Effects of non-DHPR Ca Channel Blockers |
|
Definition
Less potent vasodilator
Decreases HR, contractility, and decreases rate of recovery of Ca channels to slow conduction through AV node
Decreases coronary resistance
Increases coronary blood flow
Decreases oxygen demand of myocytes |
|
|
Term
|
Definition
A non-DHPR Ca Channel blocker
Used for angina (esp in individuals with higher HR), SVT, atrial tachycardia, atrial flutter, and atrial fibrillation |
|
|
Term
|
Definition
Non-DHPR Ca Channel blocker
Used in Angina, SVT, Atrial tachycardia, atrial fibrillation, and atrial flutter
It is also a non-specific antagnoist for the SNS to reduce the reflex tachycardia produced by vasodilation |
|
|
Term
|
Definition
A DHPR Ca Channel blocker Used in angina for people with low HR
Long acting form is much safer
Can cause reflex tachycardia (increase HR and contractility) |
|
|
Term
|
Definition
A DHPR Ca Channel blocker
Used in variant angina vasospasm
It has a high affinity for cerebral vessesl and may reduce vasospasm after subarachnoid hemorrhage |
|
|
Term
|
Definition
A vasodilator
Effects: direct relaxation of arterial smooth muscle to reduce TPR
Used in Hypertension, especially in pregnancy
Contraindicated in patients with HTN and CAD or people > 40 years old
Can lead to ischemia because of increase oxygen demand on the heart
Should co-administer with sympatholytic like a Beta blocker |
|
|
Term
|
Definition
A vasodilator
Effects: direct arteriole relaxation to reduce TPR
Also helps grow hair
Actives ATP modulated K channels to hyperpolarize the smooth muscle
Contraindicated in HTN with LVH
Should co-administer with sympatholytic drugs like Beta blockers |
|
|
Term
|
Definition
A vasodilator
Effects: arteriole and venule vasodilatin to reduce TPR
Also reduces preload to decrease O2 demand on heart
Used for hypertensive emergenices and acute MI
A prodrug that activates cGMP to reduce contractile state of smooth muscle
Metabolized by smooth muscle into nitrous oxide
Must be given via IV infusion |
|
|
Term
|
Definition
An Alpha 1 Antagonist
Inhibits vasoconstriction induced by catecholamines
Effects: Reduces arterial resistance and venous capacitance to reduce TPR
Used in HTN
First dose phenomenon is common
Not effective as a sole treatment for HTN |
|
|
Term
|
Definition
An adrenergic inhibitor that is concentrated in NE vesicles and depletes NE to inhibit the function of postganglionic adrenergic neurons
Effects: Reduces sympathetic activation to reduce TPR
Adverse effects: postural hypotension, sexual dysfunction, and diarrhea, delayed or retrograde dysfunction
Blocks excitation-secretion coupling |
|
|
Term
|
Definition
An adrenergic inhibitor that binds to storage vesicles in central and peripheral adrenergic neurons
Inhibits sympathetic effects to reduce TPR
Adverse effects: CNS sedation, inability to concentrate, and depression |
|
|
Term
|
Definition
An Alpha 2 Agonist
Depletes neuronal stores of NE by blocking feedback mechanisms
Reduces sympathetic activity to reduce TPR
Can be used for HTN in pregnancy
Adverse effects: Hypersensitivity, reduced libido, sedation, depression, blunted sympathetic effects
Very difficult drug to tolerate |
|
|
Term
|
Definition
An Alpha 2 Agonist
Depletes neuronal stores of NE by blocking feedback mechanisms to reduce TPR
High doses also activate alpha 2 receptors in vascular smooth muscle - vasodilation
Used for HTN |
|
|
Term
|
Definition
A Beta Blocker
Blocks endogenous sympathetic Beta 1 stimulation of the cardiac SA node and ventricular muscle
Effects: reduces myocarial contractility, reduces cardiac output, and decreases renin and ANG II levels
Used for HTN, angina, and arrhythmias
African Americans can have a lesser response
Side effects: ED, depression, insomnia
Contraindicated in asthma
Decreases mortality after MI |
|
|
Term
|
Definition
A DHPR Calcium Channel blocker used in HTN
Reduces vascular resistance and BP by decreases influx of Ca into arterial smooth muscle cells and cardiac myocytes
Special population: HTN in low HR and AA
Angina, arrhythmias
Long acting is best |
|
|
Term
|
Definition
A diuretic that inhibits Na-Cl cotransport in the distal tubule
Decreases blood volume, reduces preload, SV, and CO
Long term use decreases vascular resistance
Used in HTN
Adverse effects: impotence, hypokalemia
Drug interaction: quinidine |
|
|
Term
|
Definition
A K sparing diuretic that blocks Na channels in the collecting duct
Decreases BV, reduces preload, SV, and CO
Long term use decreases vascular resistance
Used in HTN along with a thiazide diuretic like hydrochlorothiazide |
|
|
Term
|
Definition
An ACE inhibitor that reduces aldosterone secretion
Reduces vasoconstriction and decreases Na retention
Used in HTN, LVH regression, delay of progression of heart failure and MI, especially good for diabetics
Adverse effects: cough, teratogenic, decreases GFR (do not use in renal failure)
Does not invoke a reflex tachycardia |
|
|
Term
|
Definition
An ARB that maintains bradykinin levels
Reduces vasoconstriction and decreases Na retention
Used in HTN but is not shown to be particularly helpful in special populations
Contraindicated in pregnancy |
|
|
Term
|
Definition
An ester local anesthetic that has a shorter duration of action
Used for topical pain, especially eye surgery
Adverse effects: HTN, tachycardia, arrhythmias, and vasoconstriction
Metabolized by plasma and liver pseudocholinesterases
Has a high abuse potential
May produce allergies - PABA |
|
|
Term
|
Definition
An ester local anesthetic that has shorter duration of action
Used mostly for infiltration and peripheral nerve blocks
Has a low systemic toxicity
Also known as Novocaine
May cause allergies - PABA |
|
|
Term
|
Definition
An amide local anesthetic that has a rapid onset and longer duration of action
Used for pain and arrhythmias
Combine with epinephrine to prevent vasodilation
Metabolized by microsomal enzymes
Most commonly used local anesthetic |
|
|
Term
|
Definition
An amide local anesthetic with rapid onset and longer duration of action
Has lower cardiac effects than some other local anesthetics
Exists in S-isoform |
|
|
Term
Carbon monoxide poisoning |
|
Definition
Poison that blocks oxygen transport
Route: inhalation
Classic sx: pink flushed skin
Antidote: high partial pressure O2 |
|
|
Term
|
Definition
Poison that blocks oxygen transport systems
Sources: nitrates, aromatics, and nitro compounds
Mechanism: Ferric iron (Fe3) binds to hemoglobin
Classic Sx: chocolate brown blood
Antidote: methylene blue |
|
|
Term
|
Definition
Poison that alters enzyme activity
Mechanism: blocks cytochrome oxidase
Sx: CNS effects, mydriasis, cyanosis, systemic sx
Antidote:
1. methemoglobin formation with amylnitrate and NaNO, 2. inactivation of poisoning with sodium thiosulfate |
|
|
Term
|
Definition
Poison that alters enzyme activity
Source: insecticide inhalants (used for lice)
Mechanism: phosphorylates AChesterase
Cholinergic crisis causes vomiting, tremors, lethargy, ab pain, fasisculations, headache, SLUD, and mioisis
Antidote
1. Block ACh with atropine
2. Reactive AChesterase with Pralidoxine
Also renders it inert |
|
|
Term
Solvent poisoning
(Kerosene, Gasoline, Diesel, Paint Thinner) |
|
Definition
Poison that alters membranes
Route: inhalation and ingestion
Causes CNS depression, V-Fib, and at risk for aspiration
Antidote: supportive care and possibly cathartics
Do not induce emesis or lavage |
|
|
Term
|
Definition
A heavy metal poison that alters membranes
Route: ingestion
Mechanisms: iron sites get saturated, can be corrosive to the GI tract
Can cause hepatic dysfunction and permanent bowel obstruction
Antidote: deferoxamine chelating agent |
|
|
Term
|
Definition
Heavy metal poisoning that can alter membranes
Routes: elemental via ingestion, ionic/inorganic via inhalation
Mechanisms: targets the CNS, kidneys
Organic version can be bioaccumulated in foods
Can cause erethism (felt hats)
Temporary blindness and red spots
Antidote: BAL (dimercaprol) chelating agent |
|
|
Term
|
Definition
Heavy metal poison that alters membranes
Routes: ingestion, exposure
Can lead to developmental learning disabilites
Antidote: calcium disodium (EDTA) |
|
|
Term
|
Definition
Heavy metal poison that alters membranes
Routes: industrial exposure
Can cause lung damage (alpha AT dysfunction), osteomalacia, immunosuppressant, growth retardation, carcinogen
Has a very long half life
Antidote: Calcium disodium (EDTA) |
|
|
Term
|
Definition
Poison that alters membranes
Routes: inhalation, ingestion, dermal, and ocular
Ex: battery |
|
|
Term
|
Definition
Free radical poison
Routes: inhalation, percutaneous absorption, ingestion
Effects: nausea, vomiting, dizziness, headache, stupor, convulsions, coma, death, CNS depression, medullary depression, V-Fib
Ingestion can cause ab pain, hematemesis, and hepatic damage |
|
|
Term
|
Definition
Reactive oxygen species that is used as an herbicide
Effects: lung toxicity, vomiting, burning pain in the mouth, throat, and lethargy
Tx: dialysis |
|
|
Term
|
Definition
Nerve fiber that releases glutamate into the dorsal horn
Fibers are myelinated
Send a quick propagation of the AP
Produces a fast onset, intense pain that subsides quickly |
|
|
Term
|
Definition
Nerve fibers that release Substance P into the dorsal horn
The nerve fibers are unmyelinated
Slow propagation of the AP
Produces a later dull pain that lasts a long time
Another effect causes mast cell degranulation and histamine release leading to vasodilation, immune cell release, inflammation, and further pain |
|
|
Term
|
Definition
Cocaine
Procaine
Tetracaine
Benzocaine |
|
|
Term
|
Definition
Lidocaine
Mepivacaine
Bupivacaine
Etidocaine
Prilocaine
Ropivacaine |
|
|
Term
|
Definition
The inherent capacity of a substance to produce injury
Estimated by LD50 |
|
|
Term
|
Definition
Practical certainty that injury will occur when a substance is used in a stated quantity and set of conditions
Also known as proportionate risk |
|
|
Term
|
Definition
Practical certainty that injury will not occur when a substance is used in a stated quantity and set of conditions
Also known as acceptable risk |
|
|
Term
|
Definition
Assessment to determine amount and conditions that can be used without appreciable risk of injury.
Affected by route of exposure (inhalation, ingestion), duration of exposure (acute or chronic), and the presence of mixtures (what the chemical is) |
|
|